SCHEMBL23923270

SCHEMBL23923270

CCCCCCCCNC(=O)CCC(CP(=O)(OCC)OCC)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP2 P42575 1/20 0.43
NAAA Q02083 1/20 0.41
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
FAAH O00519 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
LPAR3 Q9UBY5 4/20 0.38
LPAR1 Q92633 4/20 0.37
LPAR2 Q9HBW0 2/20 0.37
ENPP2 Q13822 1/20 0.37
S1PR2 O95136 2/20 0.36
S1PR1 P21453 2/20 0.36
S1PR3 Q99500 2/20 0.36
S1PR5 Q9H228 1/20 0.36
NAPEPLD Q6IQ20 1/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21805170 1.00 CASP2 (0.43) CASP2NAAAMEN1ALDH1A1MAPT
SCHEMBL21805185 0.80 DGKA (0.46) LPAR3LPAR1LPAR2ENPP2
SCHEMBL21804792 0.77 PPARD (0.40) MEN1MAPTKMT2A
SCHEMBL7747761 0.74 CASP2 (0.59) CASP2NAAAFAAHL3MBTL1LPAR1
SCHEMBL29552983 0.73 NOD1 (0.52) CASP2KMT2ALPAR3LPAR1
SCHEMBL13853974 0.73 CASP2 (0.57) CASP2NAAAFAAHL3MBTL1LPAR1
SCHEMBL18248592 0.72 CASP2 (0.56) CASP2NAAAFAAHLPAR3LPAR1
SCHEMBL19220632 0.71 SMN1; SMN2 (0.39) SMN1; SMN2
SCHEMBL20152067 0.71 CASP2 (0.53) CASP2NAAAFAAHL3MBTL1LPAR3
SCHEMBL30783475 0.70 NOD1 (0.50) CASP2NAAAFAAHL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166087-B Screening agent and use thereof 恩多塞特公司 2024-05-10 CN disclosed
US-20210323985-A1 SHIELDING AGENTS AND THEIR USE ENDOCYTE INC (US) 2021-10-21 US disclosed
CN-113166087-A Shielding agent and application thereof 恩多塞特公司 2021-07-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323985-A1 SHIELDING AGENTS AND THEIR USE PSMA6, PSMA2, PSMA1 CASP2 3128/4885NAAA 2166/4885MEN1 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.